The detection of cancer biomarkers represents an important aspect of cancer diagnosis and prognosis. Recently, the concept of liquid biopsy has been introduced whereby diagnosis and prognosis are...
Read More »Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells
Precise rare-cell technologies require the blood to be processed immediately or be stabilized with fixatives. Such restrictions limit the translation of circulating tumor cell (CTC)-based liquid biopsy assays that provide accurate molecular data in guiding clinical decisions. Here researchers from ...
Read More »Liquid Biopsy Test Identifies Androgen Receptor Protein Expression in Circulating Tumor Cells in Women with Metastatic Breast Cancer
Epic Sciences along with researchers at the MD Anderson Cancer Center (MDA) have recently published their findings on androgen receptor (AR) protein expression in circulating tumor cells (CTCs) in patients with metastatic breast cancer in PLOS One. The publication, the ...
Read More »Agena Bioscience Introduces New Lung and Colon Cancer Panels for Detection of Somatic Mutations from Liquid Biopsies
Agena Bioscience today introduced new targeted research panels for the detection of somatic mutations from lung and colon cancers. The UltraSEEK™ Lung and Colon Panels enable detection of mutations as low as 0.1% minor allele frequency (MAF) from circulating tumor ...
Read More »Liquid Biopsy in Non-Small Cell Lung Cancer
Liquid biopsy analyses are already incorporated in the routine clinical practice in many hospitals and oncology departments worldwide, improving the selection of treatments and monitoring of lung cancer patients. Although they have not yet reached its full potential, liquid biopsy-based ...
Read More »New tool to track circulating cancer cells
Cancerous tumours are known to release cells into the bloodstream, and it is these circulating tumour cells or CTCs that are the sources of metastatic tumours – tumours that spread and form in distant locations in the body. In fact, ...
Read More »Nanotube chip captures and analyzes circulating tumor cells (and exosomes) in blood
from Nanowerk by Michael Berger – Early and accurate detection of cancer is critical for successful cancer therapies. In most cases, a tissue biopsy is the initial means of making a diagnosis. With increasing accuracy, liquid biopsies – where circulating ...
Read More »Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells
Liquid biopsy of tumor through isolation of circulating tumor cells (CTCs) allows non-invasive, repetitive, and systemic sampling of disease. Although detecting and enumerating CTCs is of prognostic significance in metastatic cancer, it is conceivable that performing molecular and functional characterization ...
Read More »Caution Advised in Leaping on the Liquid Biopsy Bandwagon
from OncLive by Meir Rinde – The booming field of research on blood tests for cancer has drawn billions in venture capital funding and raised the hopes of doctors and patients for a new era of detection and treatment. A ...
Read More »Liquid Biopsies Landscape – Circulating Biomarkers Drive the Development of Liquid Biopsies
from Genetic Engineering News by Enal Razvi and Gary Oosta The field of liquid biopsies is rapidly expanding and evolving. Select Biosciences sought to map the dynamics of this evolution by analyzing the scientific literature that comprises not only the ...
Read More »